Pharsight

Endo Ventures Ltd patents expiration

1. Sumavel Dosepro patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8343130 ENDO VENTURES LTD Needleless injector
Oct, 2022

(11 months ago)

US8491524 ENDO VENTURES LTD Needleless injector drug capsule and a method for filling thereof
Nov, 2022

(10 months ago)

US8241244 ENDO VENTURES LTD Needleless injector drug capsule and a method for filling thereof
Nov, 2022

(10 months ago)

US8267903 ENDO VENTURES LTD Casing
Mar, 2023

(6 months ago)

US8241243 ENDO VENTURES LTD Needleless injector drug capsule and a method for filling thereof
Aug, 2023

(a month ago)

US8118771 ENDO VENTURES LTD Needleless injector drug capsule and a method for filling thereof
Aug, 2023

(a month ago)

US8287489 ENDO VENTURES LTD Device for readying a needle free injector for delivery
Dec, 2024

(1 year, 2 months from now)

US7901385 ENDO VENTURES LTD Casing
Jul, 2026

(2 years from now)

US7776007 ENDO VENTURES LTD Device for readying a needle free injector for delivery
Nov, 2026

(3 years from now)

Drugs and Companies using SUMATRIPTAN SUCCINATE ingredient

Market Authorisation Date: 15 July, 2009

Treatment: NA

Dosage: INJECTABLE;SUBCUTANEOUS

More Information on Dosage

SUMAVEL DOSEPRO family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic